comparemela.com

Latest Breaking News On - Psybio therapeutics corp - Page 4 : comparemela.com

PsyBio Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update on Intellectual Property and Clinical Development Milestones

/CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), a fully integrated and intellectual property driven biotechnology.

United statesInternational financial reporting standardsPsybio therapeutics corpMiami universityClinical development milestonesDrug administrationBio therapeuticsClinical developmentInvestigational new drugUnited states foodNorth americaPsybio therapeutics corpMental healthHealth care amp hospitalsMedical pharmaceuticals

2022-05-06 | TSXV:PSYB | Press Release | PsyBio Therapeutics

(2022-05-06 | TSXV:PSYB) PsyBio Therapeutics Initiates Blood-Brain Barrier Permeability Testing for Pipeline Compounds to Enhance Portfolio Development

United statesMichael spigarelliEvan levinePsybio therapeutics corpLesotho companyEverest pharma pty ltdDrug administrationPsybio therapeutics further expands testingBio therapeuticsInvestigational new drugChief medicalChief executiveEverest pharmaSouthern africaPsybio therapeuticsHealthcare 37

PsyBio Therapeutics Initiates Blood-Brain Barrier Permeability Testing for Pipeline Compounds to Enhance Portfolio Development

/CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), a fully integrated and intellectual property driven biotechnology.

United statesMichael spigarelliEvan levinePsybio therapeutics corpLesotho companyEverest pharma pty ltdDrug administrationPsybio therapeutics further expands testingBio therapeuticsInvestigational new drugChief medicalChief executiveEverest pharmaSouthern africaPsybio therapeutics corp

PsyBio Therapeutics Begins Filing Global Provisional Patent Conversion Applications to Further Strengthen Biosynthetic Patent Portfolio

/CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), a fully integrated and intellectual property driven biotechnology.

United statesMiami universityMichael spigarelliEvan levinePsybio therapeutics corpMiami university in oxfordDrug administrationPsybio therapeuticsBio therapeuticsNorth americaInvestigational new drugUnited states foodChief executiveChief medicalInvestigational new drug applicationsPsybio therapeutics corp

PsyBio Therapeutics Announces Proposed Acquisition of Everest Pharma (Pty) Ltd , a Lesotho Company in Southern Africa, as Part of Its Ongoing Impact Investment Strategy

/CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an integrated and intellectual property driven biotechnology company.

United statesMichael spigarelliEvan levinePsybio therapeutics corpLesotho companyEverest pharma pty ltdDrug administrationVenture exchangePsybio therapeuticsMake significant environmentalPromote mentalNeurological health while workingDevelop stateSmart technologiesProcess skillsBio therapeutics

vimarsana © 2020. All Rights Reserved.